Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Quest Laboratories Ltd

QUESTLAB.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.90

▲ +0.76%

Market Cap $14.81M · Vol 8.40K

Key Metrics

P/E Ratio

9.45

FWD: N/A

Market Cap

$14.81M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

40.00

Momentum

Beta

N/A

vs Market

52W High

$1.59

43.82% below

52W Low

$0.88

2.98% above

Volume

8.40K

Avg 27.08K

P/B

1.77

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Quest Laboratories Ltd (QUESTLAB.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does QUESTLAB.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.76%

-6.94%

-19.91%

-33.46%

YTD

-21.44%

-13.28%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$11.97M
Net Income	$1.61M
Revenue Growth (YoY)	N/A
Gross Margin	22.06%
Operating Margin	15.58%
Net Profit Margin	13.43%
ROE	N/A
ROA · ROIC	15.56% · 15.27%

P/E Ratio	9.45
Forward P/E (FY1)	N/A
PEG Ratio	1.07
P/S	1.53
P/B	1.77
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	16.39M

Technical Indicators

50-Day SMA	$0.98
200-Day SMA	$1.08
RSI (14)	40.00
Beta	N/A
52-Week High	$1.59
52-Week Low	$0.88

Volume Today	8.40K
Avg Daily Volume (30D)	27.08K
Relative Volume	0.31x
Volatility (10D)	24.73
Volatility (30D)	43.70
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.90

Mean Target N/A

52W Low$0.88 52W High$1.59

Current

Target

$0.88 $1.59

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG01MVWDZR4

ISININE0TNW01017

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.67% JNJ Johnson & Johnson +1.04% ABBV Abbvie Inc -0.17% NVS Novartis AG -0.53% NOVN.S Novartis AG -0.52%

Company Profile

Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.